Immunoassay Market Analysis

Product (Reagents & Kits, Analysis Equipment, Software & Services)

The reagents & kits segment in the immunoassay market is estimated to gather the highest revenue share of 68% by 2037. This segment is also predicted to grow at the highest CAGR of 7.48% over the forecast period. This growth of the segment is set to be dominated by the growing prevalence of autoimmune disease. Currently, it is predicted that there has been a growing prevalence of autoimmune diseaseS by about 2% and 9% a year in the world. Moreover, the availability of a broad range of specified and premium reagents and kits plays an important role in acknowledging precise and reproducible immunology analysis. Furthermore, the segment is characterized by continued change, such as the evolution of sensitive and specific reagents, and the integration of automation and artificial intelligence technologies. Hence, this segment is predicted to observe growth further encouraging market growth.

Specimen (Blood, Saliva, Urine, Others)

The blood segment is set to capture the highest revenue share of 56% in the immunoassay market by the end of 2037. Blood specimens are mostly utilized to estimate a wide range of parameters, such as antigens, antibodies, immune cell populations, cytokines, and other biomarkers. Valuable information about the functioning of the immune system, autoimmune disorders, allergies, and the reaction to therapies are provided by this estimation. Moreover, the examination of blood-derived cells has a central role in biomedical research and healthcare. Cells of interest are usually blood leucocytes, cord blood stem cells, bone marrow aspirates, tissue extracts, or cultured cells. As a result, the blood segment is predicted to gather the highest revenue which is additionally estimated to influence the market movement.

Our in-depth analysis of the global immunoassay market includes the following segments: